Literature DB >> 27682504

Optic nerve head slope-based quantitative parameters for identifying open-angle glaucoma on SPECTRALIS OCT images.

Abdel-Razzak M Al-Hinnawi1, Bassam O Al-Naami2, Motasem M Al-Latayfeh3.   

Abstract

PURPOSE: To investigate monitoring slope-based features of the optic nerve head (ONH) cup as open-angle glaucoma (OAG) occurs.
METHOD: A dataset of 46 retrospective OCT cases was acquired from the SPECTRALIS Heidelberg Engineering OCT device. A set of five parameters, which are based on the ONH cup-incline, are measured on the OAG and normal subjects in the dataset. Then, three new ONH cup-shape indices were deduced. The ONH cup-incline parameters and ONH cup-shape indices are analyzed to estimate their clinical value.
RESULTS: The statistical difference between measurements on normal and glaucoma eyes was remarkably significant for all of the analyzed parameters and indices (p value < 0.001).
CONCLUSIONS: The geometric shape of the ONH cup can be transferred to numerical parameters and indices. The proposed ONH cup-incline parameters and ONH cup-shape indices have shown suggestive clinical value to identify the development of OAG. As OAG appears, the top ONH cup-incline parameters decrease while the bottom ONH cup-incline parameters increase. The ONH cup-shape indices suggest capability to discriminate OAG from normal eyes.

Entities:  

Keywords:  Image feature analysis; Open-angle glaucoma; Optical coherence tomography; Optical nerve head

Mesh:

Year:  2016        PMID: 27682504     DOI: 10.1007/s10792-016-0362-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  27 in total

1.  Ultrahigh-resolution full-field optical coherence tomography.

Authors:  Arnaud Dubois; Kate Grieve; Gael Moneron; Romain Lecaque; Laurent Vabre; Claude Boccara
Journal:  Appl Opt       Date:  2004-05-10       Impact factor: 1.980

Review 2.  Spectral domain optical coherence tomography in the diagnosis and management of glaucoma.

Authors:  Ahmad A Aref; Donald L Budenz
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Nov-Dec

3.  The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT.

Authors:  Giacomo Savini; Piero Barboni; Vincenzo Parisi; Michele Carbonelli
Journal:  Br J Ophthalmol       Date:  2011-02-24       Impact factor: 4.638

4.  Slope analysis of the optic disc in eyes with ocular hypertension and early normal tension glaucoma by confocal scanning laser ophthalmoscope.

Authors:  J Dong; E Chihara
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

5.  Epidemiology of glaucoma: what's new?

Authors:  Colin Cook; Paul Foster
Journal:  Can J Ophthalmol       Date:  2012-06       Impact factor: 1.882

6.  Optic disc cup slope and visual field indices in normal, ocular hypertensive and early glaucomatous eyes.

Authors:  A B Cullinane; A Waldock; J P Diamond; J M Sparrow
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

7.  Comparison of ganglion cell and retinal nerve fiber layer thickness in primary open-angle glaucoma and normal tension glaucoma with spectral-domain OCT.

Authors:  Penpe Gul Firat; Selim Doganay; Ersan Ersin Demirel; Cemil Colak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-18       Impact factor: 3.117

8.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

9.  The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway.

Authors:  Jonathan M Skarie; Brian A Link
Journal:  Hum Mol Genet       Date:  2008-05-10       Impact factor: 6.150

10.  Intraeye retinal nerve fiber layer and macular thickness asymmetry measurements for the discrimination of primary open-angle glaucoma and normal tension glaucoma.

Authors:  Safal Khanal; Pinakin Gunvant Davey; Lyne Racette; Madhu Thapa
Journal:  J Optom       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.